Furthermore, HFD led to metabolic disorders, including compromised glucose tolerance (Fig. 1D) and insulin sensitivity (Fig. 1E), and increased blood glucose levels under fasting condition (Fig. 1F). The gene discussed is INS; the disease is metabolic disease.